374 related articles for article (PubMed ID: 21606506)
1. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
Heltemes-Harris LM; Willette MJ; Ramsey LB; Qiu YH; Neeley ES; Zhang N; Thomas DA; Koeuth T; Baechler EC; Kornblau SM; Farrar MA
J Exp Med; 2011 Jun; 208(6):1135-49. PubMed ID: 21606506
[TBL] [Abstract][Full Text] [Related]
2. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
[No Abstract] [Full Text] [Related]
3. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
[TBL] [Abstract][Full Text] [Related]
4. Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia.
Heltemes-Harris LM; Larson JD; Starr TK; Hubbard GK; Sarver AL; Largaespada DA; Farrar MA
Oncogene; 2016 Jun; 35(26):3454-64. PubMed ID: 26500062
[TBL] [Abstract][Full Text] [Related]
5. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
[TBL] [Abstract][Full Text] [Related]
6. Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.
Liu GJ; Cimmino L; Jude JG; Hu Y; Witkowski MT; McKenzie MD; Kartal-Kaess M; Best SA; Tuohey L; Liao Y; Shi W; Mullighan CG; Farrar MA; Nutt SL; Smyth GK; Zuber J; Dickins RA
Genes Dev; 2014 Jun; 28(12):1337-50. PubMed ID: 24939936
[TBL] [Abstract][Full Text] [Related]
7. Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.
Ungerbäck J; Åhsberg J; Strid T; Somasundaram R; Sigvardsson M
J Exp Med; 2015 Jun; 212(7):1109-23. PubMed ID: 26056231
[TBL] [Abstract][Full Text] [Related]
8. Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
Heltemes-Harris LM; Hubbard GK; LaRue RS; Munro SA; Yang R; Henzler CM; Starr TK; Sarver AL; Kornblau SM; Farrar MA
Oncogene; 2021 Oct; 40(43):6166-6179. PubMed ID: 34535769
[TBL] [Abstract][Full Text] [Related]
9. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5.
Roessler S; Györy I; Imhof S; Spivakov M; Williams RR; Busslinger M; Fisher AG; Grosschedl R
Mol Cell Biol; 2007 Jan; 27(2):579-94. PubMed ID: 17101802
[TBL] [Abstract][Full Text] [Related]
10. Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.
Prasad MA; Ungerbäck J; Åhsberg J; Somasundaram R; Strid T; Larsson M; Månsson R; De Paepe A; Lilljebjörn H; Fioretos T; Hagman J; Sigvardsson M
Blood; 2015 Jun; 125(26):4052-9. PubMed ID: 25838350
[TBL] [Abstract][Full Text] [Related]
11. Early B-cell factor 1 regulates the expansion of B-cell progenitors in a dose-dependent manner.
Åhsberg J; Ungerbäck J; Strid T; Welinder E; Stjernberg J; Larsson M; Qian H; Sigvardsson M
J Biol Chem; 2013 Nov; 288(46):33449-61. PubMed ID: 24078629
[TBL] [Abstract][Full Text] [Related]
12. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
[TBL] [Abstract][Full Text] [Related]
13. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
[No Abstract] [Full Text] [Related]
14. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex.
Bullerwell CE; Robichaud PP; Deprez PML; Joy AP; Wajnberg G; D'Souza D; Chacko S; Fournier S; Crapoulet N; Barnett DA; Lewis SM; Ouellette RJ
Sci Rep; 2021 Jan; 11(1):1537. PubMed ID: 33452395
[TBL] [Abstract][Full Text] [Related]
15. Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development.
Timblin GA; Schlissel MS
J Immunol; 2013 Nov; 191(9):4676-87. PubMed ID: 24068669
[TBL] [Abstract][Full Text] [Related]
16. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.
Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G
Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912
[TBL] [Abstract][Full Text] [Related]
17. The PAX5-JAK2 translocation acts as dual-hit mutation that promotes aggressive B-cell leukemia via nuclear STAT5 activation.
Jurado S; Fedl AS; Jaritz M; Kostanova-Poliakova D; Malin SG; Mullighan CG; Strehl S; Fischer M; Busslinger M
EMBO J; 2022 Apr; 41(7):e108397. PubMed ID: 35156727
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.
Heckl D; Schwarzer A; Haemmerle R; Steinemann D; Rudolph C; Skawran B; Knoess S; Krause J; Li Z; Schlegelberger B; Baum C; Modlich U
Mol Ther; 2012 Jun; 20(6):1187-95. PubMed ID: 22472950
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.
Welsh SJ; Churchman ML; Togni M; Mullighan CG; Hagman J
Leukemia; 2018 Jan; 32(1):38-48. PubMed ID: 28555080
[TBL] [Abstract][Full Text] [Related]
20. STAT5 in B cell development and leukemia.
Malin S; McManus S; Busslinger M
Curr Opin Immunol; 2010 Apr; 22(2):168-76. PubMed ID: 20227268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
